Bisoprolol: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{SS}} | {{CMG}}; {{AE}} {{SS}} | ||
'''''For patient information about Bisoprolol, click [[Bisoprolol (patient information)|here]]''''' | '''''For patient information about Bisoprolol, click [[Bisoprolol (patient information)|here]].''''' | ||
{{SB}} ZEBETA<sup>®</sup> | {{SB}} ZEBETA<sup>®</sup> | ||
Revision as of 03:43, 10 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Bisoprolol, click here.
Synonyms / Brand Names: ZEBETA®
Overview
Bisoprolol is a drug belonging to the group of beta blockers, a class of drugs used primarily in cardiovascular diseases. More specifically, it is a selective type β1 adrenergic receptor blocker [1].
Category
Beta blockers
FDA Package Insert
ZEBETA (bisoprolol fumarate) tablet
Indications and Usage | Dosage and Administration | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
The mechanism of action of its antihypertensive effects has not been completely established. Factors which may be involved include:
- Decreased cardiac output,
- Inhibition of renin release by the kidneys,
- Diminution of tonic sympathetic outflow from the vasomotor centers in the brain.